Navigation Links
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
Date:7/17/2009

trated clinical activity and safety in prior human studies. In laboratory tests, peramivir has shown activity against various viral strains, including the novel influenza A (H1N1) virus. In the U.S., BioCryst is preparing plans for additional Phase 3 studies of i.v. peramivir to support product registration. Additionally, i.v. peramivir is currently undergoing a pre-emergency use authorization (EUA) review.

About the Shionogi & Co., Ltd. Partnership

In February 2007, BioCryst & Shionogi & Co., Ltd. entered into an exclusive license agreement under which Shionogi obtained rights to develop and commercialize peramivir in Japan for the treatment of seasonal and potentially life-threatening influenza. In 2008, Shionogi's rights were extended to include Taiwan. Under the terms of the agreement, BioCryst may receive future clinical and commercial event milestone payments up to $116 million, as well as double digit royalty payments on product sales of peramivir. BioCryst retains its rights to commercialize peramivir in countries outside of Japan, Taiwan and South Korea.

About BioCryst

BioCryst is a biopharmaceutical company that has developed a diverse pipeline of novel therapeutics targeting major illnesses by employing crystallography and structure-based drug design. BioCryst is currently advancing investigational new drugs discovered in-house in late-stage clinical trials for influenza and lymphoma. In addition, the Company has a pre-clinical portfolio of novel compounds, directed against infectious, cardiovascular and autoimmune disease targets, to create long-term sustainable value. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings Ltd. validate its scientific foundation and the utility of its product candidates. For more
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
2. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
3. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
4. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
5. BioCryst Updates Peramivir Clinical Development Plan
6. BioCryst Provides Forodesine HCl Update
7. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
8. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
9. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
10. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
11. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015  Dynatronics Corporation (NASDAQ: DYNT ) ... First Annual Ladenburg Thalmann Healthcare Conference at the ... H. Cullimore, Jr. , Chairman and President, is ... on Tuesday, September 29 at 10:30 a.m. EDT.  ... showcase leading-edge companies in the healthcare arena. Mr. ...
(Date:9/1/2015)... Sept. 1, 2015 Konica Minolta Medical Imaging ... (CR) system, designed to deliver enterprise level imaging to ... same Control Station as the Konica Minolta AeroDR wireless ... upgrade path from CR to DR. The SIGMA II ... improve workflow with unparalleled reliability and high capacity to ...
(Date:9/1/2015)... , Sept. 1, 2015 Emerus Holdings, ... of emergent, inpatient and diagnostic care in partnership ... signed a definitive agreement to receive a strategic ... Carson), a leading health care investment firm. ... high-quality, patient-centric acute episodic and ambulatory clinical services ...
Breaking Medicine Technology:Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
...  ERT (Nasdaq: ERT ), announced today that ... is scheduled to present at the Citi 2012 Global ... 2012 in New York. Interested parties may ... at http://www.ert.com . The webcast may also be ...
... a leading developer of stereotactic radiosurgery and cancer ... CyberKnife cancer center, which will begin treating patients ... through a partnership between Accelitech, physicians and Swedish ... Chicago will provide state-of-the-art CyberKnife treatment to patients ...
Cached Medicine Technology:ERT to Present at the Citi 2012 Global Health Care Conference February 29, 2012 2Accelitech to Open the First CyberKnife Cancer Center Within the City of Chicago 2
(Date:9/1/2015)... Boston, MA (PRWEB) , ... September 01, 2015 , ... ... the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of ... has the same mission – to raise awareness of the FSH Society and further ...
(Date:9/1/2015)... ... 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, received ... the Best” firm in the U.S., as well as being ranked a Top 100 ... the U.S., selected exclusively on performance in specific areas of financial and operational management. ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Nurse Scholar-in Residence at the Institute of Medicine (IOM) of the National Academies. ... at Columbia University School of Nursing. A member of the Institute of Medicine ...
(Date:9/1/2015)... ... , ... Ogawa’s new massage chairs tout innovative functionality that change the way ... before. With the goal of bringing wellness to the world, Ogawa introduces their new ... As in its name, the Ogawa Refresh aims to “refresh” and rejuvenate ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... barriers and international borders seldom arise at the most convenient time for everyone ... always ready to help. , Universal Translation Services has real people ...
Breaking Medicine News(10 mins):Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3
... , TUESDAY, April 3 (HealthDay News) -- Recent reports showing ... may be the result of a glitch in the way ... treatment breakthrough, a new study suggests. "We had ... 2003 and 2009, the number of admissions to hospitals for ...
... next generation of global health scientists, Fogarty International Center ... are building a network of U.S. academic institutions to ... significant mentored research experience in a developing country. ... the next five years to support 400 early-career health ...
... - Anurag Singh, PhD, assistant professor in the ... University School of Medicine has been invited to ... colon cancer at the American Association of Cancer ... seminar, scheduled for Tuesday April 3rd, will be ...
... TUESDAY, April 3 (HealthDay News) -- Taller, heavier women may ... An international research group examined data from 47 studies ... ovarian cancer and 81,000 women without the disease. Every ... significant increase in the odds of developing ovarian cancer, the ...
... to teach us about how our planet works. Further, movies like ... an important role, can inspire us to pay closer attention to them. ... our planet,s vegetation? The public has an opportunity to find out ... physiology at the University of California, Riverside and the botanical consultant ...
... interest in other children? Does he enjoy playing peek-a-boo and ... he respond to his name when you call? If you ... early signs of autism, which affects more than one in ... research reveals that parents can play a major role in ...
Cached Medicine News:Health News:Reported Decline in U.S. Pneumonia Deaths May Be False: Study 2Health News:Reported Decline in U.S. Pneumonia Deaths May Be False: Study 3Health News:NIH awards $20 million over 5 years to train next generation of global health researchers 2Health News:NIH awards $20 million over 5 years to train next generation of global health researchers 3Health News:Taller, Heavier Women May Face Higher Ovarian Cancer Risk 2Health News:What can Hollywood teach us about our planet? 2Health News:What can Hollywood teach us about our planet? 3Health News:'An Early Start for Your Child with Autism' 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: